Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
10 déc. 2021 17h00 HE
|
Anika Therapeutics Inc.
BEDFORD, Mass., Dec. 10, 2021 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that on December 1,...
Anika to Participate in Upcoming Investor Conferences
18 nov. 2021 16h01 HE
|
Anika Therapeutics Inc.
BEDFORD, Mass., Nov. 18, 2021 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that Dr. Cheryl...
Anika Reports Third Quarter 2021 Financial Results
04 nov. 2021 16h05 HE
|
Anika Therapeutics Inc.
Revenue growth of 25% year-over-yearCompany revises revenue growth outlook for 2021 to 9-11% on COVID Delta headwinds BEDFORD, Mass., Nov. 04, 2021 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc....
Anika Appoints Sheryl Conley to Board of Directors
01 nov. 2021 09h00 HE
|
Anika Therapeutics Inc.
BEDFORD, Mass., Nov. 01, 2021 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company focused on early intervention orthopedics, today announced that its...
Anika to Issue Third Quarter 2021 Financial Results on Thursday, November 4, 2021
18 oct. 2021 09h00 HE
|
Anika Therapeutics Inc.
BEDFORD, Mass., Oct. 18, 2021 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that the Company...
Anika Launches the WristMotion® Total Wrist Arthroplasty System at the American Society for Surgery of the Hand Annual Meeting
30 sept. 2021 09h00 HE
|
Anika Therapeutics Inc.
BEDFORD, Mass., Sept. 30, 2021 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company, today announced its WristMotion® Total Wrist Arthroplasty (TWA)...
Tactoset® Injectable Bone Substitute Now FDA Cleared for Hardware Augmentation
14 sept. 2021 09h00 HE
|
Anika Therapeutics Inc.
BEDFORD, Mass., Sept. 14, 2021 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company focused on early intervention orthopedics, today announced that it has...
Anika to Participate in the Morgan Stanley 19th Annual Global Healthcare Conference
07 sept. 2021 10h00 HE
|
Anika Therapeutics Inc.
BEDFORD, Mass., Sept. 07, 2021 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company focused on early intervention orthopedics, today announced that Dr....
Anika to Debut Joint Preservation Portfolio at the 2021 AAOS Annual Meeting
01 sept. 2021 10h05 HE
|
Anika Therapeutics Inc.
BEDFORD, Mass., Sept. 01, 2021 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company focused on early intervention orthopedics, will debut their full joint...
Anika Reports Second Quarter 2021 Financial Results
05 août 2021 16h05 HE
|
Anika Therapeutics Inc.
Revenue growth of 24% year-over-yearCompany raises full year revenue growth outlook to 11-14% BEDFORD, Mass., Aug. 05, 2021 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global...